Gilead Sciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
GILD Nasdaq 2836 www.gilead.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Gilead Sciences, Inc.

Three Stocks That May Be Trading Below Estimated Value In May 2026 - May 29th, 2026 11:38 am
Discover May 2026's Stocks That Could Be Trading Below Estimated Value - May 29th, 2026 5:37 am
Allogene CEO to step down; Agios drug fails key test - May 29th, 2026 4:17 am
Gilead (GILD) Wins FDA Approval for First HDV Treatment Hepcludex - May 29th, 2026 12:04 am
S&P 500, Nasdaq Rise to Another Record. Software Strikes Back. - May 28th, 2026 2:01 pm
Novel Spanish, Culturally Adapted Metastatic Breast Cancer Symptom Management Guide Debuts at ASCO 2026 - May 28th, 2026 5:05 am
FDA accelerated approval of Hepcludex significant milestone for US HDV market - May 28th, 2026 4:47 am
3 Stocks Estimated To Be Trading Up To 44.8% Below Intrinsic Value - May 26th, 2026 11:38 am
3 Stocks Estimated To Be Trading At Discounts Of Up To 44.1% - May 26th, 2026 5:38 am
Astellas eyes more cost cuts; FDA panel to debate Moderna vaccine - May 26th, 2026 4:16 am
Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio - May 25th, 2026 1:54 pm
Three Stocks That May Be Trading Below Their Estimated Value In May 2026 - May 25th, 2026 11:38 am
GILD Scores FDA Win for HDV Drug, CHMP Backs Trodelvy - May 25th, 2026 8:59 am
May 2026's Top Stocks That Could Be Trading Below Estimated Fair Value - May 25th, 2026 5:38 am
Maxim Upgrades Gilead Sciences (GILD) to ‘Buy’ - May 24th, 2026 11:26 am
Gilead Sciences Highlights Trodelvy Lung Data, Long-Acting HIV Pipeline at RBC Conference - May 24th, 2026 7:03 am
Is It Time To Reassess Gilead Sciences (GILD) After Strong Multi Year Share Price Gains - May 23rd, 2026 1:18 am
Sector Update: Healthcare Stocks Gain Late Afternoon - May 22nd, 2026 1:23 pm
GILD Stock Jumps After Winning Accelerated FDA Approval For HDV Treatment - May 22nd, 2026 1:08 pm
FDA Grants Accelerated Approval to Gilead’s Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV) - May 22nd, 2026 12:00 pm